Cariporide enables hemodynamically more effective chest compression by leftward shift of its flow-depth relationship

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 6 57-6, 2005, Pages

  Kolarova, Julieta D ^b   Ayoub, Iyad M ^b   Gazmuri, Raúl J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Cardiopulmonary resuscitation; Defibrillation; Fluorescent microspheres; Sodium hydrogen antiporter; Ventricular fibrillation

Indexed keywords

CARIPORIDE; MICROSPHERE;

ADRENAL BLOOD FLOW; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BRAIN BLOOD FLOW; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; DRUG ACTIVITY; DRUG MECHANISM; FLUORESCENCE; HEART INDEX; HEART VENTRICLE FIBRILLATION; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CHEST WALL OSCILLATION; ELECTRIC COUNTERSHOCK; GUANIDINES; HEMODYNAMIC PROCESSES; MALE; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; SULFONES; VENTRICULAR FUNCTION, LEFT;

EID: 19344366139     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.01181.2004     Document Type: Article

References (45)

1. Avkiran M. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol 83: 10G-17G, 1999.
2. Ayoub IM, Kolarova JD, Yi Z, Trevedi A, Deshmukh H, Lubell DL, Franz MR, Maldonado FA, and Gazmuri RJ. Sodium-hydrogen exchange inhibition during ventricular fibrillation: beneficial effects on ischemic contracture, action potential duration, reperfusion arrhythmias, myocardial function, and resuscitability. Circulation 107: 1804-1809, 2003.
3. Babbs CF, Voorhees WD, Fitzgerald KR, Holmes HR, and Geddes LA. Relation of blood pressure and flow during CPR to chest compression amplitude: evidence for an effective compression threshold. Ann Emerg Med 12: 527-532, 1983.
4. Bellamy RF, DeGuzman LR, and Pedersen DC. Coronary blood flow during cardiopulmonary resuscitation in swine. Circulation 69: 174-180, 1984.
5. Bersohn MM. Sodium pump inhibition in sarcolemma from ischemic hearts. J Mol Cell Cardiol 27: 1483-1489, 1995.
6. Buckberg GD, Luck JC, Payne DB, Hoffman JI, Archie JP, and Fixler DE. Some sources of error in measuring regional blood flow with radioactive microspheres. J Appl Physiol 31: 598-604, 1971.
7. Dean JM, Koehler RC, Schleien CL, Michael JR, Chantarojanasiri T, Rogers MC, and Traystman RJ. Age-related changes in chest geometry during cardiopulmonary resuscitation. J Appl Physiol 62: 2212-2219, 1987.
8. Deshmukh HG, Weil MH, Gudipati CV, Trevino RP, Bisera J, and Rackow EC. Mechanism of blood flow generated by precordial compression during CPR. I. Studies on closed chest precordial compression. Chest 95: 1092-1099, 1989.
9. Ditchey RV and Horwitz LD. Metabolic evidence of inadequate coronary blood flow during closed-chest resuscitation in dogs. Cardiovasc Res 19: 419-425, 1985.
10. Duggal C, Weil MH, Gazmuri RJ, Tang W, Sun S, O'Connell F, and Ali M. Regional blood flow during closed-chest cardiac resuscitation in rats. J Appl Physiol 74: 147-152, 1993.
11. Fluorescent Microsphere Resource Center. Manual for Using Fluorescent Microspheres to Measure Regional Organ Perfusion. University of Washington, Division of Pulmonary and Critical Care Medicine, 1999. Available online: http://frmc.pulmcc.washington.edu/DOCUMENTS/FMRCMAN99.pdf.
12. + exchange. Cardiovasc Res 35: 80-89, 1997.
13. Gazmuri RJ, Ayoub IM, Hoffner E, and Kolarova JD. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide. Circulation 104: 234-239, 2001.
14. Gazmuri RJ, Berkowitz M, and Cajigas H. Myocardial effects of ventricular fibrillation in the isolated rat heart. Crit Care Med 27: 1542-1550, 1999.
15. Gervais M, Demolis P, Domergue V, Lesage M, Richer C, and Giudicelli JF. Systemic and regional hemodynamics assessment in rats with fluorescent microspheres. J Cardiovasc Pharmacol 33: 425-432, 1999.
16. Glenny RW, Bernard S, and Brinkley M. Validation of fluorescent-labeled microspheres for measurement of regional organ perfusion. J Appl Physiol 74: 2585-2597, 1993.
17. Halestrap AP, Clarke SJ, and Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion - a target for cardioprotection. Cardiovasc Res 61: 372-385, 2004.
18. Halestrap AP, Connern CP, Griffiths EJ, and Kerr PM. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury. Mol Cell Biochem 174: 167-172, 1997.
19. Imahashi K, Kusuoka H, Hashimoto K, Yoshioka J, Yamaguchi H, and Nishimura T. Intracellular sodium accumulation during ischemia as the substrate for reperfusion injury. Circ Res 84: 1401-1406, 1999.
20. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, and Sollott SJ. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113: 1535-1549, 2004.
21. + exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs 61: 375-389, 2001.
22. Klouche K, Weil MH, Sun S, Tang W, Povoas HP, Kamohara T, and Bisera J. Evolution of the stone heart after prolonged cardiac arrest. Chest 122: 1006-1011, 2002.
23. Kolarova JD, Yi Z, Ayoub IM, and Gazmuri RJ. Cariporide potentiates the effects of epinephrine and vasopressin by non-vascular mechanisms during closed-chest resuscitation. Chest. In press.
24. Krischer JP, Fine EG, Davis JH, and Nagel EL. Complications of cardiac resuscitation. Chest 92: 287-291, 1987.
25. Lederer W, Mair D, Rabl W, and Baubin M. Frequency of rib and sternum fractures associated with out-of-hospital cardiopulmonary resuscitation is underestimated by conventional chest X-ray. Resuscitation 60: 157-162, 2004.
26. + current blockers. Am J Physiol Heart Circ Physiol 269: H533-H540, 1995.
27. Luce JM, Rizk NA, and Niskanen RA. Regional blood flow during cardiopulmonary resuscitation in dogs. Crit Care Med 12: 874-878, 1984.
28. Ma MH, Hwang JJ, Lai LP, Wang SM, Huang GT, Shyu KG, Ko YL, Lin JL, Chen WJ, and Hsu KL. Transesophageal echocardiographic assessment of mitral valve position and pulmonary venous flow during cardiopulmonary resuscitation in humans. Circulation 92: 854-861, 1995.
29. Porter TR, Ornato JP, Guard CS, Roy VG, Burns CA, and Nixon JV. Transesophageal echocardiography to assess mitral valve function and flow during cardiopulmonary resuscitation. Am J Cardiol 70: 1056-1060, 1992.
30. Raab S, Thein E, Harris AG, and Messmer K. A new sample-processing unit for the fluorescent microsphere method. Am J Physiol Heart Circ Physiol 276: H1801-H1806, 1999.
31. Rabl W, Baubin M, Broinger G, and Scheithauer R. Serious complications from active compression-decompression cardiopulmonary resuscitation. Int J Legal Med 109: 84-89, 1996.
32. Redberg RF, Tucker KJ, Cohen TJ, Dutton JP, Callaham ML, and Schiller NB. Physiology of blood flow during cardiopulmonary resuscitation. A transesophageal echocardiographic study. Circulation 88: 534-542, 1993.
33. Scholz W and Albus U. Potential of selective sodium-hydrogen exchange inhibitors in cardiovascular therapy. Cardiovasc Res 29: 184-188, 1995.
34. Scholz W, Albus U, Counillon L, Gogelein H, Lang HJ, Linz W, Weichert A, and Scholkens BA. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res 29: 260-268, 1995.
35. Sharff JA, Pantley G, and Noel E. Effect of time on regional organ perfusion during two methods of cardiopulmonary resuscitation. Ann Emerg Med 13: 649-656, 1984.
36. Sigurdsson G, Yannopoulos D, McKnite SH, and Lurie KG. Cardiorespiratory interactions and blood flow generation during cardiac arrest and other states of low blood flow. Curr Opin Crit Care 9: 183-188, 2003.
37. 2+ overload and prolonged acidosis on reperfusion. Circulation 101: 2749-2755, 2000.
38. +exchanger in hypoxia/reoxygenation-induced neonatal rat cardiomyocyte apoptosis. Eur J Pharmacol 486: 121-131, 2004.
39. Takino M and Okada Y. Firm myocardium in cardiopulmonary resuscitation. Resuscitation 33: 101-106, 1996.
40. + exchange inhibitor, inhibits the mitochondrial death pathway. Circulation 108: 2275-2281, 2003.
41. Thein E, Raab S, Harris AG, Kleen M, Habler O, Meisner F, and Messmer K. Comparison of regional blood flow values measured by radioactive and fluorescent microspheres. Eur Surg Res 34: 215-223, 2002.
42. Thein E, Raab S, Harris AG, and Messmer K. Automation of the use of fluorescent microspheres for the determination of blood flow. Comput Methods Programs Biomed 61: 11-21, 2000.
43. + current by R56865 in single cardiac Purkinje cells. Eur J Pharmacol 203: 371-378, 1991.
44. von Planta I, Weil MH, von Planta M, Bisera J, Bruno S, Gazmuri RJ, and Rackow EC. Cardiopulmonary resuscitation in the rat. J Appl Physiol 65: 2641-2647, 1988.
45. + exchanger activity and expression in human ventricular myocardium. J Am Coll Cardiol 36: 534-540, 2000.